PlumX Metrics
Embed PlumX Metrics

The linkage between the second wave of COVID-19 and the severity of mucormycosis in India

Journal of Applied Biology and Biotechnology, ISSN: 2347-212X, Vol: 9, Issue: 6, Page: 41-50
2021
  • 0
    Citations
  • 0
    Usage
  • 4
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

The whole world was fighting the danger of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) since 2019. The SARS-CoV-2 virus was mutating with great speed, and putting new challenges in front of the world. In India, the whole healthcare system was engaged in tackling the second wave of COVID-19 as a result of virus mutation. Additionally, a fungal co-infection, mucormycosis started to invade the COVID-19 patients. Mucormycosis is an acute infection, caused by an opportunistic fungus, mostly attacks the immunosuppressed, diabetic, and neutropenia patients. The other causes of infection include inappropriate use of immunosuppressive drugs, entry of Mucorales through open wounds, cancer, acquired immune deficiency syndrome, organ transplant, and malnutrition. In the recent mucormycosis outbreak in India, all the mucormycosis cases included eyesight damage, facial deformities, and even death in critical conditions. These reported mucormycosis cases in India were mostly diabetes, which were treated with immunosuppressive drugs. The mucormycosis fungus was probably invading the recovered, or near to recovery the second wave COVID-19 patients. In this review, we discussed the important risk factors responsible for the sudden outbreak of mucormycosis, and its severity linked to second wave COVID-19 patients in India.

Bibliographic Details

Kshama Wamanrao Murarkar,; Shilpa Prakash Mankar

Open Science Publishers LLP

Biochemistry, Genetics and Molecular Biology; Agricultural and Biological Sciences

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know